Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith press release on Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended March 31, 2023. Windlas Biotech Ltd - 543329 - Post-Buyback Public Announcement
Corporate Professionals Capital Pvt Ltd ("Manager to the Buyback") has submitted to BSE a copy of Post-Buyback Public Announcement for the attention of Equity Shareholders/Beneficial Owners of Equity Shares of Windlas Biotech Ltd ("the Company"). Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement
Post Buyback Advertisement for the Buyback of Equity Shares of Windlas Biotech Limited ('WBL' or 'the Company') from Open Market through Stock Exchange Mechanism in terms of the provisions of Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Closure of Buy Back
Intimation of completion of Buyback by Windlas Biotech Limited ('the Company') in terms of the provisions of Securities & Exchange Board of India (Buy Back of Securities) Regulations, 2018 ('Buyback Regulations') through Open Market Route Windlas Biotech Ltd - 543329 - Intimation of completion of Buyback through Open Market Route
Windlas Biotech Ltd has informed BSE regarding "Intimation of completion of Buyback by Windlas Biotech Limited ('the Company') in terms of the provisions of Securities & Exchange Board of India (Buy Back of Securities) Regulations, 2018 ("Buyback Regulations") through Open Market Route. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018 Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
This is to inform that, pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 37,358 (Thirty Seven Thousand Three Hundred Fifty Eight) equity shares bought back under the Buy-back during the period from April 17, 2023 till April 25, 2023. In connection with the same, we are submitting herewith the Certificate of Extinguishment for your records. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the conference call to discuss financial performance of the Company for the quarter and financial year ended March 31, 2023 is scheduled to be held as per the details given herein.